Federico Arcamone

5.3k total citations · 1 hit paper
132 papers, 4.0k citations indexed

About

Federico Arcamone is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Federico Arcamone has authored 132 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 56 papers in Organic Chemistry and 47 papers in Oncology. Recurrent topics in Federico Arcamone's work include Cancer Treatment and Pharmacology (33 papers), Cancer therapeutics and mechanisms (21 papers) and Microbial Natural Products and Biosynthesis (19 papers). Federico Arcamone is often cited by papers focused on Cancer Treatment and Pharmacology (33 papers), Cancer therapeutics and mechanisms (21 papers) and Microbial Natural Products and Biosynthesis (19 papers). Federico Arcamone collaborates with scholars based in Italy, Germany and France. Federico Arcamone's co-authors include Giuseppe Cassinelli, P. Orezzi, Sergio Penco, G. FRANCESCHI, A. Grein, C. Spalla, Anna Maria Casazza, Milena Menozzi, Silvana Penco and Graziella Pratesi and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Federico Arcamone

130 papers receiving 3.7k citations

Hit Papers

Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibio... 1969 2026 1988 2007 1969 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius
    1969 477 citations Federico Arcamone et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federico Arcamone Italy 35 2.0k 1.3k 1.2k 712 653 132 4.0k
Tad H. Koch United States 35 2.0k 1.0× 1.3k 1.0× 520 0.4× 218 0.3× 160 0.2× 158 3.9k
Arlette Garnier‐Suillerot France 36 1.6k 0.8× 501 0.4× 1.7k 1.4× 139 0.2× 216 0.3× 119 3.2k
Giovanni Capranico Italy 47 4.9k 2.4× 1.0k 0.8× 2.0k 1.6× 353 0.5× 385 0.6× 144 6.2k
David J. Maloney United States 43 3.3k 1.6× 991 0.8× 905 0.7× 175 0.2× 390 0.6× 140 5.6k
Ghanem Atassi Belgium 34 1.6k 0.8× 1.6k 1.2× 1.1k 0.9× 81 0.1× 318 0.5× 189 3.6k
Robert S. McDowell United States 28 2.8k 1.4× 969 0.8× 563 0.5× 517 0.7× 207 0.3× 44 4.3k
Thomas G. Burke United States 33 2.5k 1.2× 454 0.4× 1.2k 0.9× 63 0.1× 445 0.7× 61 3.3k
Richard Bertrand Canada 31 2.2k 1.1× 455 0.4× 856 0.7× 109 0.2× 104 0.2× 82 3.5k
Christian Auclair France 38 2.5k 1.2× 691 0.5× 588 0.5× 54 0.1× 203 0.3× 143 4.5k
Ward W. Smith United States 28 2.0k 1.0× 506 0.4× 583 0.5× 178 0.3× 187 0.3× 38 3.4k

Countries citing papers authored by Federico Arcamone

Since Specialization
Citations

This map shows the geographic impact of Federico Arcamone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Arcamone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Arcamone more than expected).

Fields of papers citing papers by Federico Arcamone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Arcamone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Arcamone. The network helps show where Federico Arcamone may publish in the future.

Co-authorship network of co-authors of Federico Arcamone

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Arcamone. A scholar is included among the top collaborators of Federico Arcamone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Arcamone. Federico Arcamone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernardini, Sara, Rodolfo Iuliano, Giulia Freer, et al.. (2008). In vitro Antiviral Activity of Distamycin A against Clinical Isolates of Herpes Simplex Virus 1 and 2 from Transplanted Patients. Intervirology. 51(3). 166–172. 7 indexed citations
2.
Arcamone, Federico, et al.. (2000). Synthesis and Biological Activity of the Penem Antibiotic MEN 10700 and Its Orally Absorbed Ester MEN 11505.. The Journal of Antibiotics. 53(10). 1086–1095. 4 indexed citations
3.
Arcamone, Federico, Fabio Animati, Mario Bigioni, et al.. (1999). Configurational requirements of the sugar moiety for the pharmacological activity of anthracycline disaccharides. Biochemical Pharmacology. 57(10). 1133–1139. 25 indexed citations
4.
Catalioto, R.-M., Marco Criscuoli, Paola Cucchi, et al.. (1998). MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist. British Journal of Pharmacology. 123(1). 81–91. 78 indexed citations
5.
Arcamone, Federico. (1998). From the pigments of the actinomycetes to third generation antitumor anthracyclines. Biochimie. 80(3). 201–206. 47 indexed citations
6.
Arcamone, Federico, Fabio Animati, Giovanni Capranico, et al.. (1997). New developments in antitumor anthracyclines. Pharmacology & Therapeutics. 76(1-3). 117–124. 94 indexed citations
7.
Zunino, Franco, Paola Perego, Silvana Pilotti, et al.. (1997). Role of apoptotic response in cellular resistance to cytotoxic agents. Pharmacology & Therapeutics. 76(1-3). 177–185. 67 indexed citations
8.
Triolo, Antonio, Federico Arcamone, Andrea Raffaelli, & Piero Salvadori. (1997). Non-covalent complexes between DNA-binding drugs and double-stranded deoxyoligonucleotides: a study by ionspray mass spectrometry. Journal of Mass Spectrometry. 32(11). 1186–1194. 51 indexed citations
9.
Zimmer, Ch., et al.. (1996). Deformyldistamycin-DNA Interaction; DNA Conformational Changes as Revealed by Titration Rotational Viscometry. Journal of Biomolecular Structure and Dynamics. 14(2). 245–253. 4 indexed citations
10.
Animati, Fabio, Federico Arcamone, Maria R. Conte, et al.. (1995). Synthesis of Two Distamycin Analogs and Their Binding Mode to d(CGCAAATTTGCG)2 in the 2:1 Solution Complexes as Determined by Two-Dimensional 1H-NMR. Journal of Medicinal Chemistry. 38(7). 1140–1149. 11 indexed citations
11.
Quartara, Laura, Riccardo Patacchini, Vittorio Pestellini, et al.. (1994). Influence of Lipophilicity on the Biological Activity of Cyclic Pseudopeptide NK-2 Receptor Antagonists. Journal of Medicinal Chemistry. 37(21). 3630–3638. 11 indexed citations
12.
Ciucci, Alessandra, Giordana Feriotto, Carlo Mischiati, et al.. (1994). Distamycin analogues with improved sequence-specific DNA binding activities. Biochemical Pharmacology. 48(8). 1583–1591. 9 indexed citations
13.
Dapporto, Paolo, et al.. (1994). Absolute configuration and biological activity of mequitamium iodide enantiomers. Chirality. 6(5). 382–388. 4 indexed citations
14.
Colonna, Francesco Paolo, et al.. (1993). L-DNAs as potenital antimessenger oligonucleotides: a reassessment. Nucleic Acids Research. 21(18). 4159–4165. 69 indexed citations
15.
Arcamone, Federico. (1988). Chemical approaches in anticancer drug development. Cancer Treatment Reviews. 15(1). 65–68. 1 indexed citations
16.
Battaglia, R., et al.. (1982). Metabolism of metergoline in the rat.. PubMed. 37(10). 651–62. 1 indexed citations
17.
A, Di Marco, Fernando C. Giuliani, Graziella Pratesi, et al.. (1978). Synthesis and antitumor activity of 4-demethoxyadriamycin and 4-demethoxy-4' -epiadriamycin.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(3). 375–80. 12 indexed citations
18.
Arcamone, Federico. (1977). New antitumor anthracyclines.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 40(1). 45–66. 84 indexed citations
19.
Arcamone, Federico, et al.. (1976). The effect of distamycin A on some biochemical functions of tissue cultures infected with Herpes simplex virus.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 31(10). 705–13. 3 indexed citations
20.
Prakash, Chandra, et al.. (1971). Some structural requirements for the antibiotic action of distamycins. FEBS Letters. 16(4). 249–252. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tad H. Koch Breakdown of academic impact, for papers by Arlette Garnier‐Suillerot Breakdown of academic impact, for papers by Giovanni Capranico Breakdown of academic impact, for papers by David J. Maloney Breakdown of academic impact, for papers by Ghanem Atassi Breakdown of academic impact, for papers by Robert S. McDowell Breakdown of academic impact, for papers by Thomas G. Burke Breakdown of academic impact, for papers by Richard Bertrand Breakdown of academic impact, for papers by Christian Auclair Breakdown of academic impact, for papers by Ward W. Smith
Rankless by CCL
2026